Sign Out
Non-Small Cell Lung Cancer: Zefei is indicated in combination with cisplatin for the first-line treatment of patients with inoperable, locally advanced (stage IIIA or IIIB) or metastatic (stage IV) non-small cell lung cancer.
Pancreatic Cancer: Zefei is indicated as first-line treatment for patients with locally advanced (nonresectable stage II or stage III) or metastatic (stage IV) adenocarcinoma of the pancreas. It is also indicated for patients previously treated with 5-FU.
